<DOC>
	<DOCNO>NCT02923375</DOCNO>
	<brief_summary>The purpose study assess safety , tolerability efficacy two infusion CYP-001 adult steroid-resistant GvHD .</brief_summary>
	<brief_title>A Study CYP-001 Treatment Steroid-Resistant Acute Graft Versus Host Disease</brief_title>
	<detailed_description>This multi-centre , open label , dose escalation study ass safety , tolerability efficacy two infusion CYP-001 , adults steroid-resistant GvHD . Participants receive standard care treatment throughout study , accord local procedure . The first eight participant enrol Cohort A receive CYP-001 dose 1 million cell per kg , maximum dose 100 million cell , Day 0 Day 7 . Subject safety review data Cohort A , additional eight participant enrol Cohort B receive CYP-001 dose 2 million cells/kg , maximum dose 200 million cell , Day 0 Day 7 . The primary evaluation period conclude participant 100 day first dose CYP-001 . Participants study visit Days 0 , 3 , 7 , 14 , 21 , 28 , 60 100 . Subsequently , participant enter long term follow-up period , conclude 2 year first dose CYP-001 .</detailed_description>
	<mesh_term>Graft v Host Disease</mesh_term>
	<criteria>Diagnosis use consensus grade steroidresistant Grade IIIV acute GvHD , haematopoietic stem cell transplant haematological disorder . Life expectancy least one month . Agree followup data collect two year initial dose CYP001 ( separate protocol ) . Pregnant breastfeeding plan become pregnant within three month receive last dose CYP001 . Have receive investigational research agent within 30 day five halflives ( whichever longer ) prior first dose IMP . Known suspect current alcohol substance abuse problem . Progressive relapse haematological malignancy , current solid tumour , previous malignant solid tumour likely recur period study ( exception past history basal squamous cell carcinoma ) . ECOG score equal great 3 Heart failure ( NYHA Functional Class IIIV ) and/or pulmonary failure . Haemodynamically unstable and/or high risk cardiovascular event . Terminal organ failure . Sepsis , meningitis , pneumonia hypoxemia , HIV another severe systemic infection .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>March 2017</verification_date>
</DOC>